UROTHELIAL CANCER
Clinical trials for UROTHELIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UROTHELIAL CANCER trials appear
Sign up with your email to follow new studies for UROTHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Global hunt for answers on new bladder cancer drug duo
Disease control Not yet recruitingThis study is looking back at the real-world results of a two-drug combination (enfortumab vedotin plus pembrolizumab) used as the first treatment for people with advanced bladder cancer that has spread. It aims to collect information from around the world to see how long patient…
Matched conditions: UROTHELIAL CANCER
Sponsor: Aron Research Foundation Ets • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for advanced bladder cancer patients in pfizer drug trial
Disease control Not yet recruitingThis study is testing a new medicine, PF-08634404, for adults with advanced bladder cancer that has spread. It will see if the drug is safe, how well it works to control the cancer, and how the body processes it. One group will get the new drug alone, and another group will get i…
Matched conditions: UROTHELIAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New gel treatment aims to save kidneys from cancer surgery
Disease control Not yet recruitingThis study is testing a combination of two chemotherapy drugs, delivered directly into the kidney, to treat a specific type of upper urinary tract cancer. The main goal is to see if this approach can effectively control the cancer while allowing patients to keep their kidney, avo…
Matched conditions: UROTHELIAL CANCER
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
First human test of 'Cancer Spotlight' imaging drug begins
Diagnosis Not yet recruitingThis is a first-in-human study to test the safety of a new imaging drug called [18F]DK222. The drug is designed to stick to a specific protein (PD-L1) on cancer cells, potentially making tumors show up more clearly on a PET/CT scan. The trial will enroll 6 adults with lung or bla…
Matched conditions: UROTHELIAL CANCER
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Diagnosis
Last updated Mar 23, 2026 15:16 UTC
-
Massive 3,000-Patient study to track real bladder cancer treatment outcomes
Knowledge-focused Not yet recruitingThis study aims to understand how well current treatments work for advanced bladder cancer in everyday medical practice. Researchers will review existing health records of 3,000 U.S. patients who started treatment after April 2023. The study will track how long treatments keep th…
Matched conditions: UROTHELIAL CANCER
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Mar 17, 2026 12:55 UTC